Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

4.78
Delayed Data
As of Sep 23
 -0.11 / -2.25%
Today’s Change
3.55
Today|||52-Week Range
19.46
-53.95%
Year-to-Date
No recent news for Osiris Therapeutics Inc.

Today’s Trading

Previous close4.89
Today’s open4.80
Day’s range4.75 - 4.86
Volume55,055
Average volume (3 months)84,339
Market cap$164.7M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio97.7
Price/Sales9.15
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
EVGNEvogene Ltd0.000.00%
ENZYEnzymotec Ltd-0.21-2.95%
GNCAGenocea Biosciences ...+0.02+0.37%
ADVMAdverum Biotechnolog...+0.01+0.24%
Data as of 3:59pm ET, 09/23/2016

Financials

Last reporting dateMay 6, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
David A. Dresner
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Search for Jobs